Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 10;90(13):6014-6021.
doi: 10.1128/JVI.00494-16. Print 2016 Jul 1.

RNA-Free and Ribonucleoprotein-Associated Influenza Virus Polymerases Directly Bind the Serine-5-Phosphorylated Carboxyl-Terminal Domain of Host RNA Polymerase II

Affiliations

RNA-Free and Ribonucleoprotein-Associated Influenza Virus Polymerases Directly Bind the Serine-5-Phosphorylated Carboxyl-Terminal Domain of Host RNA Polymerase II

Mónica Martínez-Alonso et al. J Virol. .

Abstract

Influenza viruses subvert the transcriptional machinery of their hosts to synthesize their own viral mRNA. Ongoing transcription by cellular RNA polymerase II (Pol II) is required for viral mRNA synthesis. By a process known as cap snatching, the virus steals short 5' capped RNA fragments from host capped RNAs and uses them to prime viral transcription. An interaction between the influenza A virus RNA polymerase and the C-terminal domain (CTD) of the large subunit of Pol II has been established, but the molecular details of this interaction remain unknown. We show here that the influenza virus ribonucleoprotein (vRNP) complex binds to the CTD of transcriptionally engaged Pol II. Furthermore, we provide evidence that the viral polymerase binds directly to the serine-5-phosphorylated form of the Pol II CTD, both in the presence and in the absence of viral RNA, and show that this interaction is conserved in evolutionarily distant influenza viruses. We propose a model in which direct binding of the viral RNA polymerase in the context of vRNPs to Pol II early in infection facilitates cap snatching, while we suggest that binding of free viral polymerase to Pol II late in infection may trigger Pol II degradation.

Importance: Influenza viruses cause yearly epidemics and occasional pandemics that pose a threat to human health, as well as represent a large economic burden to health care systems globally. Existing vaccines are not always effective, as they may not exactly match the circulating viruses. Furthermore, there are a limited number of antivirals available, and development of resistance to these is a concern. New measures to combat influenza are needed, but before they can be developed, it is necessary to better understand the molecular interactions between influenza viruses and their host cells. By providing further insights into the molecular details of how influenza viruses hijack the host transcriptional machinery, we aim to uncover novel targets for the development of antivirals.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Viral RNAs coimmunoprecipitate with Pol II. HEK 293T cells were infected with influenza A/WSN/33 virus (WSN), harvested at 4.5 hpi, and subjected to RIP. RNAs from cell lysates (input) and immunoprecipitates (IP) were analyzed by primer extension with NA (panel A) and NP (panel B) segment-specific primers. A primer specific for 5S rRNA was used as a control. Note that the sample used for analysis of the input corresponds to 1/10 of that used for the immunoprecipitations. Ab, antibody.
FIG 2
FIG 2
vRNPs from infected cell lysates bind to serine-5-phosphorylated Pol II CTD mimic peptides in vitro. HEK 293T cells were infected with influenza A/WSN/33 virus (WSN) or mock infected, harvested at 4.5 hpi, and lysed. Differentially phosphorylated Pol II CTD mimic peptides were immobilized on streptavidin agarose resin and incubated with the lysates. Bound complexes were analyzed by silver staining (top panel), Western blot analysis (middle panels) with antibodies against the viral polymerase (3P) and NP, and primer extension of viral RNAs derived from the NA segment (bottom panel). Background binding to streptavidin agarose resin without peptide was also analyzed, and total cell lysates (input) were included. S2P, Ser2P; S5P, Ser5P; UP, unphosphorylated; SCB, scrambled; B, beads; I, input. The values to the left are molecular sizes in kilodaltons.
FIG 3
FIG 3
Purified recombinant influenza virus polymerase binds to serine-5-phosphorylated Pol II CTD mimic peptides in vitro. (A) Recombinant viral polymerase from influenza A/WSN/33 (H1N1) virus was expressed in and purified from HEK 293T cells in the presence (+) or absence (−) of a 37-nt-long vRNA-like template. Peptides mimicking different phosphorylation states of the Pol II CTD (Ser2P, Ser5P, unphosphorylated) and a scrambled control peptide were immobilized on streptavidin agarose resin and incubated with purified viral polymerase. Complexes bound to the peptides were analyzed by silver staining (top), and RNA was detected by 5′-end labeling with [γ-32P]ATP (bottom). (B) Recombinant viral polymerase from influenza A/NT/60/68 (H3N2) virus was expressed in and purified from Sf9 insect cells in the presence (+) or absence (−) of 15- and 14-nt-long RNAs corresponding to the 5′ and 3′ ends of the vRNA promoter, respectively. The polymerase was incubated with the Pol II CTD mimic peptides, and bound complexes were analyzed as described for panel A. (C) Input samples of recombinant viral polymerase from panel A analyzed for the presence of contaminating host proteins and RNA. Silver staining shows higher levels of contaminating host proteins copurifying with the viral polymerase if vRNA is absent. Labeling of RNA with [γ-32P]ATP shows that, in the absence of vRNA, higher levels of contaminating cellular RNA are present, as represented by the strong smear. (D) In vitro transcription by recombinant viral polymerase from influenza A/WSN/33 (H1N1) virus expressed in and purified from HEK 293T cells in the presence of a 37-nt-long vRNA-like template, with β-globin mRNA as a cap donor. Transcription products of input polymerase are shown as a positive control (lane 1). Lanes 2 to 5 show the transcriptional activity of the polymerase captured by Pol II CTD mimic peptides immobilized on streptavidin agarose resin. Transcription products are synthesized when the polymerase is bound to a Pol II CTD mimic peptide phosphorylated on serine-5 (lanes 2 and 4). A scrambled peptide with no detectable polymerase bound is included as a negative control (lanes 3 and 5). No transcription products are obtained in the absence of the β-globin mRNA cap donor, UTP, or ATP (lanes 6 to 8). Lanes 4 and 5 show the result obtained with a 2-fold dilution of the viral polymerase, compared to that in lanes 2 and 3. (E) Influenza C/Johannesburg/1/66 virus recombinant polymerase was expressed in and purified from Sf9 insect cells. The polymerase was incubated with the peptides as described above, and bound complexes were analyzed by silver staining. S2P, Ser2P; S5P, Ser5P; UP, unphosphorylated; SCB, scrambled; B, beads; I, input. The values to the left of the panels are molecular sizes in kilodaltons for protein panels and numbers of nucleotides for RNA panels.
FIG 4
FIG 4
Model of the dual roles of the interaction of the influenza virus RNA polymerase with the CTD of the large subunit of Pol II. Early in infection (left), binding of the viral polymerase in the context of vRNP to the Pol II CTD facilitates cap snatching from nascent host capped RNA. The viral polymerase (3P) is shown in a surface model representation in the “transcription preinitiation” state with the PB2 cap-binding and PA endonuclease domains aligned for cap snatching (Protein Data Bank [PDB] code 4WSB). Late in infection (right), binding of the free viral polymerase (3P) to the Pol II CTD triggers Pol II degradation. The viral polymerase is shown in the apo conformation, with the cap-binding pocket of PB2 blocked (PDB code 5D98). PB1, dark yellow; PB2, green; PA/P3, blue.

Similar articles

Cited by

References

    1. Fodor E. 2013. The RNA polymerase of influenza A virus: mechanisms of viral transcription and replication. Acta Virol 57:113–122. doi:10.4149/av_2013_02_113. - DOI - PubMed
    1. Resa-Infante P, Jorba N, Coloma R, Ortin J. 2011. The influenza virus RNA synthesis machine: advances in its structure and function. RNA Biol 8:207–215. doi:10.4161/rna.8.2.14513. - DOI - PMC - PubMed
    1. Rodriguez-Frandsen A, Alfonso R, Nieto A. 2015. Influenza virus polymerase: functions on host range, inhibition of cellular response to infection and pathogenicity. Virus Res 209:23–38. doi:10.1016/j.virusres.2015.03.017. - DOI - PubMed
    1. Arranz R, Coloma R, Chichon FJ, Conesa JJ, Carrascosa JL, Valpuesta JM, Ortin J, Martin-Benito J. 2012. The structure of native influenza virion ribonucleoproteins. Science 338:1634–1637. doi:10.1126/science.1228172. - DOI - PubMed
    1. Moeller A, Kirchdoerfer RN, Potter CS, Carragher B, Wilson IA. 2012. Organization of the influenza virus replication machinery. Science 338:1631–1634. doi:10.1126/science.1227270. - DOI - PMC - PubMed

MeSH terms